Post-myocardial infarction (MI) recovery is often limited by mitochondrial dysfunction, ATP depletion, and oxidative stress, which impair myocardial healing and functional recovery. This white paper examines the scientific rationale behind Cardiotrition® Booster, an advanced nutritional adjunct designed to support myocardial bioenergetics and cellular resilience following ischemic cardiac injury. The report describes how Cardiotrition® Booster combines Coenzyme Q10, Alpha-Lipoic Acid, and Acetyl-L-Carnitine with proprietary CardioDrone® heart-targeting technology, Innova3® molecular enhancement, and LipoXTEND® liposomal delivery to improve bioavailability and targeted intracellular delivery. Experimental findings in H9c2 cardiomyocytes demonstrated enhanced mitochondrial membrane potential and reduced mitochondrial superoxide production, indicating improved mitochondrial function and protection against oxidative stress. The paper concludes that Cardiotrition® Booster may serve as a valuable adjunct to standard post-MI and post-angina care by supporting ATP production, reducing oxidative damage, improving exercise tolerance, and promoting cardiac recovery.
